RHOEN-KLINIKUM O.N./ DE0007042301 /
15/11/2024 15:49:02 | Chg. 0.000 | Volume | Bid17:36:12 | Ask17:36:12 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
12.500EUR | 0.00% | 418 Turnover: 5,204 |
12.400Bid Size: 255 | 12.800Ask Size: 245 | 843.42 mill.EUR | - | 21.72 |
Assets
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,827.5000 | 1,859.1000 | 1,919.7000 | 711.9000 | 663.2000 | ||||||
Intangible Assets | 346.9000 | 365.4000 | 431 | 163.1000 | 143.7000 | ||||||
Long-Term Investments | 4.9000 | 4.7000 | 15.7000 | 3.3000 | 14.7000 | ||||||
Fixed Assets | 2,195.3000 | 2,242.8000 | 2,378.3000 | 886.9000 | 846.5000 | ||||||
Inventories | 47.9000 | 50.3000 | 56.9000 | 21.1000 | 21.8000 | ||||||
Accounts Receivable | 0.0000 | 352 | 439.4000 | 160.5000 | 169.7000 | ||||||
Cash and Cash Equivalents | 415.7000 | 477.5000 | 237 | 29.9000 | 695.4000 | ||||||
Current Assets | 862.9000 | 929.2000 | 802.9000 | 2,211.3000 | 957.8000 | ||||||
Total Assets | 3,058.2000 | 3,175.3000 | 3,184.4000 | 3,098.2000 | 1,804.3000 |
Liabilities
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 151.5000 | 129 | 137.3000 | 73.4000 | 89.6000 | ||||||
Long-term debt | 922.7000 | 1,007.5000 | 833.6000 | 741.8000 | 170.2000 | ||||||
Liabilities to Banks | 992.2000 | 1,065.1000 | 1,213.7000 | 899.9000 | 199.7000 | ||||||
Provisions | 22.4000 | 20.7000 | 25.4000 | 16.2000 | 177.4000 | ||||||
Liabilities | 1,599.3000 | 1,620.3000 | 1,602.6000 | 1,453.2000 | 575.8000 | ||||||
Share Capital | 345.6000 | 345.6000 | 345.6000 | 345.6000 | 183.7050 | ||||||
Total Equity | 1,458.9000 | 1,555 | 1,581.9000 | 1,645 | 1,228.5000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 3,058.2000 | 3,175.3000 | 3,184.4000 | 3,098.2000 | 1,804.3000 |
Income Statement
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2,550.4000 | 2,629.1000 | 2,864.9000 | 3,013.8000 | 1,510.5000 | ||||||
Depreciation (total) | 109.4000 | 141.5000 | 141.2000 | 119.7000 | 82.8000 | ||||||
Operating Result | 197.9000 | 213.2000 | 150.3000 | 155.7000 | 1,330.9000 | ||||||
Interest Income | - | - | -36.7000 | -38 | -82.4000 | ||||||
Income Before Taxes | 173.9000 | 186.5000 | 113.7000 | 117.7000 | 1,248.5000 | ||||||
Income Taxes | 28.8000 | 25.4000 | 21.7000 | 27.7000 | 20.6000 | ||||||
Minority Interests Profit | -5.4000 | -5 | -2.3000 | -3.4000 | -2.2000 | ||||||
Net Income | 139.7000 | 156.1000 | 89.7000 | 86.6000 | 1,225.7000 |
Per Share
Cash Flow
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 221.5000 | 236.2000 | 139.1000 | 210.4000 | 49.2000 | ||||||
Cash Flow from Investing Activities | -316 | -188 | -180.3000 | -101.2000 | 2,879.8000 | ||||||
Cash Flow from Financing | 67.1000 | -1.5000 | -178.8000 | -212.3000 | -2,350.5000 | ||||||
Decrease / Increase in Cash | -27.4000 | 46.7000 | -220 | -103.1000 | 578.5000 | ||||||
Employees | 38,058 | 39,325 | 43,059 | 43,363 | 15,602 |